These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2389311)

  • 1. Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis.
    Badaró R; Pedral-Sampaio D; Johnson WD; Reed SG
    Trans R Soc Trop Med Hyg; 1990; 84(2):226-7. PubMed ID: 2389311
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmanin test in post-kala-azar dermal leishmaniasis.
    Neogy AB; Nandy A; Chowdhury AB
    Trans R Soc Trop Med Hyg; 1990; 84(1):58. PubMed ID: 2345927
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of a skin test antigen for American visceral leishmaniasis.
    Reed SG; Badaró R; Masur H; Carvalho EM; Lorenco R; Lisboa A; Teixeira R; Johnson WD; Jones TC
    Am J Trop Med Hyg; 1986 Jan; 35(1):79-85. PubMed ID: 3946739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.
    Gifawesen C; Farrell JP
    Infect Immun; 1989 Oct; 57(10):3091-6. PubMed ID: 2528507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants.
    Mutiso JM; Macharia JC; Taracha E; Wafula K; Rikoi H; Gicheru MM
    Rev Inst Med Trop Sao Paulo; 2012; 54(1):37-41. PubMed ID: 22370752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Leishmania donovani soluble antigen and antibody in the urine of visceral leishmaniasis patients.
    Kohanteb J; Ardehali SM; Rezai HR
    Trans R Soc Trop Med Hyg; 1987; 81(4):578-80. PubMed ID: 2451331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.
    White AC; Castes M; Garcia L; Trujillo D; Zambrano L
    Am J Trop Med Hyg; 1992 Feb; 46(2):123-31. PubMed ID: 1539745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S; Ravindran R; Ali N
    Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens.
    Mazumdar T; Anam K; Ali N
    J Parasitol; 2005 Apr; 91(2):269-74. PubMed ID: 15986599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of monoclonal antibodies against Leishmania donovani, II. Detection of circulating antigen in sera of visceral leishmaniasis before and after treatment].
    Qu JQ; Xu YX; Bao YF; Yang YT; Wang JY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):21-3. PubMed ID: 2065447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement fixation and intradermal skin test with partially purified "proteic" and "polysaccharidic" antigens from Leishmania donovani.
    La Placa M; Pampiglione S; Borgatti M; Zerbini M
    Trans R Soc Trop Med Hyg; 1975; 69(4):396-8. PubMed ID: 1216300
    [No Abstract]   [Full Text] [Related]  

  • 13. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescent antibody titres after recovery from visceral leishmaniasis.
    Basu D; Mallik KK; Bhattacharya A; Ghosh AK
    Acta Trop; 1991 Nov; 50(1):87-8. PubMed ID: 1723840
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
    Bhowmick S; Mazumdar T; Sinha R; Ali N
    J Control Release; 2010 Jan; 141(2):199-207. PubMed ID: 19818373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of circulating antigens by McAb-AST for evaluation of the therapeutic effect of kala-azar cases].
    Hu XS; Lin FQ; Liu Q; Wang YJ; Luo P; Qin Z; Bao L; Yuan HS; Lan L
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):161-4. PubMed ID: 3557420
    [No Abstract]   [Full Text] [Related]  

  • 18. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of monoclonal antibodies to assay for circulating antigen in visceral leishmaniasis.
    Evans T
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():471-5. PubMed ID: 3253509
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.